rs61750071
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000552.5(VWF):c.4120C>T(p.Arg1374Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1374H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWF | NM_000552.5 | c.4120C>T | p.Arg1374Cys | missense_variant | 28/52 | ENST00000261405.10 | NP_000543.3 | |
VWF | XM_047429501.1 | c.4120C>T | p.Arg1374Cys | missense_variant | 28/52 | XP_047285457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWF | ENST00000261405.10 | c.4120C>T | p.Arg1374Cys | missense_variant | 28/52 | 1 | NM_000552.5 | ENSP00000261405 | P1 | |
VWF | ENST00000538635.5 | n.421-25364C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250960Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135690
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461644Hom.: 0 Cov.: 38 AF XY: 0.00000550 AC XY: 4AN XY: 727134
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
von Willebrand disease type 2 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Jun 05, 2023 | The VWF c.4120C>T variant is classified as PATHOGENIC (PS4_Mod, PM2_supp, PM5, PS3, PP1_Moderate) The VWF c.4120C>T variant is a single nucleotide change in exon 28/52 of the VWF gene, which is predicted to change the amino acid arginine at position 1374 in the protein to cysteine. The variant has been reported in multiple individuals with a clinical presentation of bleeding disorders and low VWF activity to antigen ratios (PMID: 35307943, 34758185, 30817071, 31064749) (PS4_Mod). This variant is rare in population databases (gnomAD allele frequency = 0.00065%; 1 het and 0 hom in 152152 sequenced alleles) (PM2_Supp) and co-segregates with disease (PMID:16247740) (PP1_moderate). This variant is a missense change at an amino acid residue where different missense changes (p.Arg1374His, p.Arg1374Cys, p.Arg1374Leu, p.Arg1374Ser) have been seen before (PM5). in vitro and in vivo studies showed that the variant results in decreased VWF synthesis and impaired GPIb binding (PMID:28544236, 11150026) (PS3). The variant has been reported in dbSNP (rs61750071) and in the HGMD database: CM951304. It has also been reported as Pathogenic by other diagnostic laboratories (ClinVar Variation ID: 100329). - |
Pathogenic, criteria provided, single submitter | research | Laboratory of Hematology, Radboud University Medical Center | Jan 21, 2022 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico | Apr 26, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
not provided Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 14, 2023 | The VWF c.4120C>T; p.Arg1374Cys variant (rs61750071), also known as R611C, is reported in the literature in several individuals affected with von Willebrand disease type 2A or type 2M (Berber 2013, Borras 2017, Flood 2013, Goodeve 2007, Hilbert 1995, Veyradier 2016). This variant is also reported in ClinVar (Variation ID: 100329), but is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. Computational analyses predict that this variant is deleterious (REVEL: 0.757). Additionally, other amino acid substitutions at this codon (His, Leu, Ser) have been reported in individuals with von Willebrand disease type 2A or type 2M and are considered pathogenic (Borras 2017, Flood 2013, Goodeve 2007, Hilbert 1995, Veyradier 2016). Based on available information, this variant is considered to be pathogenic. References: Berber E et al. A common VWF exon 28 haplotype in the Turkish population. Clin Appl Thromb Hemost. 2013 Sep;19(5):550-6. PMID: 22473027. Borras N et al. Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients. Haematologica. 2017 Dec;102(12):2005-2014. PMID: 28971901. Corrales I et al. Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene. Thromb Haemost. 2009 Mar;101(3):570-6. PMID: 19277422. Flood VH et al. Collagen binding provides a sensitive screen for variant von Willebrand disease. Clin Chem. 2013 Apr;59(4):684-91. PMID: 23340442. Goodeve A et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood. 2007 Jan 1;109(1):112-21. PMID: 16985174. Hilbert L et al. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF. Blood. 1995 Aug 1;86(3):1010-8. PMID: 7620154. Veyradier A et al. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture. Medicine (Baltimore). 2016 Mar;95(11):e3038. PMID: 26986123. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 07, 2023 | Published functional studies demonstrate a damaging effect of this variant due to decreased secretion of von Willebrand factor, decreased collagen binding, and absent platelet glycoprotein Ib binding (PMID: 28544236, 7620154); Reported in association with von Willebrand disease types 2A and 2M (PMID: 16247740, 7620154); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as p.(R611C); This variant is associated with the following publications: (PMID: 22102201, 7620154, 25185554, 28544236, 16247740, 30817071, 27414491, 23340442, 23290978, 33556167, 31064749, 34758185) - |
not provided, no classification provided | literature only | Academic Unit of Haematology, University of Sheffield | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Feb 16, 2017 | - - |
Hereditary von Willebrand disease Pathogenic:2
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Feb 01, 2019 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital | Jul 13, 2007 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at